Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lineage Cell Therapeutics (LCTX) Shares Outstanding (Diluted Average) (2016 - 2025)

Lineage Cell Therapeutics' Shares Outstanding (Diluted Average) history spans 12 years, with the latest figure at $230.1 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Diluted Average) rose 14.95% year-over-year to $230.1 million; the TTM value through Dec 2025 reached $230.1 million, up 14.95%, while the annual FY2025 figure was $230.1 million, 14.95% up from the prior year.
  • Shares Outstanding (Diluted Average) reached $230.1 million in Q4 2025 per LCTX's latest filing, up from $228.9 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $230.1 million in Q4 2025 to a low of $158725.0 in Q1 2021.
  • Average Shares Outstanding (Diluted Average) over 5 years is $177.0 million, with a median of $172.7 million recorded in 2023.
  • The largest YoY upside for Shares Outstanding (Diluted Average) was 107248.77% in 2021 against a maximum downside of 99.89% in 2021.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $163.1 million in 2021, then rose by 4.09% to $169.8 million in 2022, then grew by 1.69% to $172.7 million in 2023, then increased by 15.94% to $200.2 million in 2024, then increased by 14.95% to $230.1 million in 2025.
  • Per Business Quant, the three most recent readings for LCTX's Shares Outstanding (Diluted Average) are $230.1 million (Q4 2025), $228.9 million (Q3 2025), and $228.4 million (Q2 2025).